My NCBI | Sign In
RSS Settings
  • Search: Valantin Marc-Antoine[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 23

    1.

    Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial.

    Meynard JL, Morand-Joubert L, Lacombe K, Poirier JM, Slama L, Valantin MA, Girard PM.

    J Antimicrob Chemother. 2009 Nov 17. [Epub ahead of print]PMID: 19919951 [PubMed - as supplied by publisher]Related articles

    2.

    Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial.

    Aslangul E, Assoumou L, Bittar R, Valantin MA, Kalmykova O, Peytavin G, Fiévet MH, Boccara F, Bonnefont-Rousselot D, Melchior JC, Giral P, Costagliola D.

    AIDS. 2009 Oct 15. [Epub ahead of print]PMID: 19838098 [PubMed - as supplied by publisher]Related articles

    3.

    Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.

    Schnuriger A, Dominguez S, Guiguet M, Harfouch S, Samri A, Ouazene Z, Slama L, Simon A, Valantin MA, Thibault V, Autran B; ANRS HC EP21 study group.

    AIDS. 2009 Oct 23;23(16):2079-89.PMID: 19710595 [PubMed - in process]Related articles

    4.

    Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.

    Ingiliz P, Valantin MA, Duvivier C, Medja F, Dominguez S, Charlotte F, Tubiana R, Poynard T, Katlama C, Lombès A, Benhamou Y.

    Hepatology. 2009 Feb;49(2):436-42.PMID: 19085967 [PubMed - indexed for MEDLINE]Related articles

    5.

    Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

    Ingiliz P, Valantin MA, Thibault V, Duvivier C, Dominguez S, Katlama C, Poynard T, Benhamou Y.

    Antivir Ther. 2008;13(7):895-900.PMID: 19043923 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).

    Slama L, Lanoy E, Valantin MA, Bastard JP, Chermak A, Boutekatjirt A, William-Faltaos D, Billaud E, Molina JM, Capeau J, Costagliola D, Rozenbaum W.

    Antivir Ther. 2008;13(1):67-76.PMID: 18389900 [PubMed - indexed for MEDLINE]Related articles

    7.

    A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndrome.

    Izzedine H, Brocheriou I, Valantin MA, Camous L, Bourry E, Baumelou A, Deray G, Katlama C.

    Nat Clin Pract Nephrol. 2008 Feb;4(2):110-4.PMID: 18227804 [PubMed - indexed for MEDLINE]Related articles

    8.

    Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro.

    Malet I, Delelis O, Valantin MA, Montes B, Soulie C, Wirden M, Tchertanov L, Peytavin G, Reynes J, Mouscadet JF, Katlama C, Calvez V, Marcelin AG.

    Antimicrob Agents Chemother. 2008 Apr;52(4):1351-8. Epub 2008 Jan 28.PMID: 18227187 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Efavirenz urolithiasis.

    Izzedine H, Valantin MA, Daudon M, Mohand HA, Caby F, Katlama C.

    AIDS. 2007 Sep 12;21(14):1992. No abstract available. PMID: 17721118 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.

    Izzedine H, Hulot JS, Villard E, Goyenvalle C, Dominguez S, Ghosn J, Valantin MA, Lechat P, Deray AG.

    J Infect Dis. 2006 Dec 1;194(11):1481-91. Epub 2006 Oct 26.PMID: 17083032 [PubMed - indexed for MEDLINE]Related articles

    11.

    Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.

    Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, Caumes E, Pialoux G, Benhamou Y, Thibault V, Katlama C.

    AIDS. 2006 May 12;20(8):1157-61. Review.PMID: 16691067 [PubMed - indexed for MEDLINE]Related articles

    12.

    Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era.

    Isnard Bagnis C, Du Montcel ST, Fonfrede M, Jaudon MC, Thibault V, Carcelain G, Valantin MA, Izzedine H, Servais A, Katlama C, Deray G.

    Nephron Physiol. 2006;103(3):p131-8. Epub 2006 Mar 23.PMID: 16557032 [PubMed - indexed for MEDLINE]Related articles

    13.

    Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors.

    Roquebert B, Malet I, Wirden M, Tubiana R, Valantin MA, Simon A, Katlama C, Peytavin G, Calvez V, Marcelin AG.

    AIDS. 2006 Jan 9;20(2):287-9.PMID: 16511425 [PubMed - indexed for MEDLINE]Related articles

    14.

    Muscle and liver lactate metabolism in HAART-treated and naive HIV-infected patients: the MITOVIR study.

    Ghosn J, Guiguet M, Jardel C, Benyaou R, Zeller V, Simon A, Valantin MA, Amellal B, Assoumo L, Hogrel JY, Costagliola D, Katlama C, Lombès A.

    Antivir Ther. 2005;10(4):543-50.PMID: 16038480 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients.

    Allavena C, Ferré V, Brunet-François C, Delfraissy JF, Lafeuillade A, Valantin MA, Bentata M, Michelet C, Poizot-Martin I, Dailly E, Launay O, Raffi F; Bitherapy Kaletra-Sustiva Study Group.

    J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):300-6.PMID: 15980689 [PubMed - indexed for MEDLINE]Related articles

    16.

    Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.

    Wirden M, Marcelin AG, Simon A, Kirstetter M, Tubiana R, Valantin MA, Paris L, Bonmarchand M, Conan F, Kalkias L, Katlama C, Calvez V.

    J Med Virol. 2005 Jul;76(3):297-301.PMID: 15902696 [PubMed - indexed for MEDLINE]Related articles

    17.

    Atazanavir: a novel inhibitor of HIV-protease in haemodialysis.

    Izzedine H, Launay-Vacher V, Peytavin G, Valantin MA, Deray G.

    Nephrol Dial Transplant. 2005 Apr;20(4):852-3. No abstract available. PMID: 15772278 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II study.

    Katlama C, Ghosn J, Tubiana R, Wirden M, Valantin MA, Harmenberg J, Mårdh G, Oberg B, Calvez V.

    AIDS. 2004 Jun 18;18(9):1299-304.PMID: 15362662 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Why antiretroviral therapy must not begin to early?]

    Valantin MA, Katlama C.

    Rev Prat. 2004 Apr 30;54(8):819-24. French. No abstract available. PMID: 15274451 [PubMed - indexed for MEDLINE]Related articles

    20.

    Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.

    Wirden M, Marcelin AG, Tubiana R, Valantin MA, Ghosn J, Duvivier C, Dominguez S, Paris L, Agher R, Peytavin G, Katlama C, Calvez V.

    J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):876-8. No abstract available. PMID: 15213573 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity